Partners and clients across industries gather at exclusive eventNEW YORK, Oct. 10, 2024 /PRNewswire/ -- Genpact (NYSE: G ), a ...
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” third quarter 2024 investor letter ...
CAMP4 Therapeutics, a biopharmaceutical firm backed by healthcare giant Kaiser Permanente raised $75 million on Thursday in its U.S. initial public offering.